Shanmuga Hospital Ltd IPO Price Range is ₹54 - ₹54, with a minimum investment of ₹1,08,000 for 2000 shares per lot.
Subscription Rate
2.431x
Minimum Investment
₹1,08,000
/ 2000 shares
IPO Status
Price Band
₹54 - ₹54
Bidding Dates
Feb 13, 2025 - Feb 17, 2025
Issue Size
₹20.62 Cr
Lot Size
2000 shares
Min Investment
₹1,08,000
Listing Exchange
BSE
IPO subscribed over
🚀 2.431x
This IPO has been subscribed by 4.407x in the retail category and 0x in the QIB category.
Total Subscription | 2.431x |
Retail Individual Investors | 4.407x |
Qualified Institutional Buyers | 0x |
Non Institutional Investors | 0.71x |
Name | Shanmuga Hospital Ltd |
Established and proven track record.
Leveraging the experience of our Promoters.
Experienced management team and a motivated and efficient work force.
Cordial relations with our customers.
Quality Assurance & Control.
The Company, Directors, Promoters and Group Companies are parties to certain legal proceedings. Any adverse decision in such proceedings may have a material adverse effect on its business, results of operations and financialconditions.
The Company has limited operating history, and therefore investors may not be able to assess its prospects on the basis of historical results.
The company is highly dependent on its healthcare professionals, including doctors, nurses that the company engage on a consultancy basis, and its business and financial results could be impacted if the company is not able to attract and retain such healthcare professionals.
The Company is yet to place orders for medical equipment proposed to be installed at its hospital. Any delay in placing orders or procurement of such equipment may delay the schedule of implementation and possibly increase the cost of commencing operations.
The company generates certain revenues from the arrangements with government sponsored health schemes, any adverse change in these regulations/government policies related to such schemes may adversely affect its business, results of operations, cash flows and prospects.
Delay in receipt of payment from its patients / customers may affect the company cash flows, which may, in turn affect its financial condition and results of operations.
The company indebtedness and the conditions and restrictions imposed by its financing arrangements may limit the company ability to grow its business and adversely impact the company business.
Changes in healthcare laws, rules and regulations may materially adversely affect its business
The Company had negative cash flow in recent fiscals, details of which are given below. Sustained negative cash flow could adversely impact its business, financial condition and results of operations.
There are certain instances of delays in the past with ROC/Statutory Authorities.